Discover the full record of transactions filed by Bellon Steven F., Directeur Scientifique. Insider active across 1 company, notably Foghorn Therapeutics Inc.. In total, 1 reports have been logged. Activity tracked since 25 May 2022. The latest transaction was disclosed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Bellon Steven F. is the Chief Scientific Officer at Foghorn Therapeutics Inc. He is responsible for leading research and development of new products. His role is essential in ensuring that Foghorn remains at the forefront of scientific innovation. His expertise in research and development contributes to the company's mission.